A/Prof Stella Valenzuela undertook her PhD studies [identifying novel genes – CLIC1 and MIC-1 – from activated macrophage cells] at the Centre for Immunology (CFI), St Vincent’s Hospital Sydney, obtaining her PhD from the University of NSW in 1998. Prior to this she had worked in the commercial sector, in the biotechnology companies Australian Monoclonal Development Pty Ltd and Cellabs Pty Ltd in research and development of monoclonal antibody technologies for research and diagnostic purposes. Following her PhD studies she was a Research Scientist at the CFI [functional studies of intracellular ion channel proteins – CLICs], later moving to the University of NSW to take up a position as an NHMRC Research Fellow [knockout mouse studies of S100 inflammatory proteins].
In June 2001 she joined the University of Technology, Key Centre for Health Technologies [cellular responses to mobile phone frequencies]. She then took up an academic position at UTS in 2004. She is currently the Associate Head of School (Research) in the School of Life Sciences, UTS.
A/Prof Valenzuela is a member of both the Centre for Health Technologies and the Institute of Nanoscale Technologies, UTS. She has been instrumental in establishing Bionanotechnology research at UTS and is currently working with her industry partner – Surgical Diagnostics Pty Ltd – developing devices that use on ion channel proteins.
Australian Society for Biophysics: 2005 to present
Australian Research Council Nanotechnology Network (ARCNN): 2007 to present